世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

神経疾患治療薬の世界市場 2022-2026


Global Neurologic Disorders Therapeutics Market 2022-2026

神経学的障害治療薬の世界市場 2022-2026 年 Technavioは神経疾患治療薬市場を監視しており、2022-2026年の間に334億6000万ドルの成長が見込まれ、予測期間中にCAGR5.44%で加速しています。神経疾患治療薬市場に... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年5月30日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

神経学的障害治療薬の世界市場 2022-2026 年
Technavioは神経疾患治療薬市場を監視しており、2022-2026年の間に334億6000万ドルの成長が見込まれ、予測期間中にCAGR5.44%で加速しています。神経疾患治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、新薬の承認、提携、共同研究、ライフスタイルの変化などによって牽引されています。
神経疾患治療薬市場の分析には、用途別セグメントと地理的展望が含まれます。
Technavioの神経疾患治療薬市場は、以下のように区分されています。
アプリケーション別
- 中枢神経系
- PNS
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、再生医療の登場が、今後数年間の神経疾患治療薬市場の成長を牽引する主要な理由の1つであると位置付けています。また、薬物の改良と神経変性適応症の診断の進歩は、市場の大きな需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。神経疾患治療薬市場に関する当レポートは、以下の分野を対象としています。
- 神経疾患治療薬市場のサイジング
- 神経疾患治療薬市場の予測
- 神経疾患治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie社、Acadia Pharmaceuticals社、Acorda Therapeutics社、Bayer AG、Biogen社、Eisai社、F. Hoffmann社などの神経系疾患の治療薬の主要ベンダーについて詳細に分析を行っています。Ltd.、F.ホフマン・ラ・ロシュ社、グラクソ・スミスクラインPlc、HルンドベックAS、ジョンソン、およびジョンソン、メルクKGaA、マイランNV、ノバルティスAG、大塚ホールディングスCo.Ltd.大塚製薬株式会社、ファイザー株式会社、サノフィ株式会社、武田薬品工業株式会社、エーザイ株式会社、株式会社エフティ資生堂Ltd.、Teva Pharmaceutical Industries Ltd.、UCB SA、および USWM LLC。また、神経疾患治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neurologic-disorders-therapeutics-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 CNS - Market size and forecast 2021-2026
o Exhibit 28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on CNS - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
o 5.4 PNS - Market size and forecast 2021-2026
o Exhibit 32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on PNS - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 Biogen Inc.
o Exhibit 88: Biogen Inc. - Overview
o Exhibit 89: Biogen Inc. - Product / Service
o Exhibit 90: Biogen Inc. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 91: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 92: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 93: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 H Lundbeck AS
o Exhibit 96: H Lundbeck AS - Overview
o Exhibit 97: H Lundbeck AS - Product / Service
o Exhibit 98: H Lundbeck AS - Key offerings
o 10.7 Johnson and Johnson
o Exhibit 99: Johnson and Johnson - Overview
o Exhibit 100: Johnson and Johnson - Business segments
o Exhibit 101: Johnson and Johnson - Key news
o Exhibit 102: Johnson and Johnson - Key offerings
o Exhibit 103: Johnson and Johnson - Segment focus
o 10.8 Novartis AG
o Exhibit 104: Novartis AG - Overview
o Exhibit 105: Novartis AG - Business segments
o Exhibit 106: Novartis AG - Key offerings
o Exhibit 107: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 108: Pfizer Inc. - Overview
o Exhibit 109: Pfizer Inc. - Product / Service
o Exhibit 110: Pfizer Inc. - Key news
o Exhibit 111: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 112: Sanofi - Overview
o Exhibit 113: Sanofi - Business segments
o Exhibit 114: Sanofi - Key news
o Exhibit 115: Sanofi - Key offerings
o Exhibit 116: Sanofi - Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on CNS - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on PNS - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ billion)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ billion)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Biogen Inc. - Overview
Exhibits89: Biogen Inc. - Product / Service
Exhibits90: Biogen Inc. - Key offerings
Exhibits91: F. Hoffmann La Roche Ltd. - Overview
Exhibits92: F. Hoffmann La Roche Ltd. - Business segments
Exhibits93: F. Hoffmann La Roche Ltd. - Key news
Exhibits94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits96: H Lundbeck AS - Overview
Exhibits97: H Lundbeck AS - Product / Service
Exhibits98: H Lundbeck AS - Key offerings
Exhibits99: Johnson and Johnson - Overview
Exhibits100: Johnson and Johnson - Business segments
Exhibits101: Johnson and Johnson - Key news
Exhibits102: Johnson and Johnson - Key offerings
Exhibits103: Johnson and Johnson - Segment focus
Exhibits104: Novartis AG - Overview
Exhibits105: Novartis AG - Business segments
Exhibits106: Novartis AG - Key offerings
Exhibits107: Novartis AG - Segment focus
Exhibits108: Pfizer Inc. - Overview
Exhibits109: Pfizer Inc. - Product / Service
Exhibits110: Pfizer Inc. - Key news
Exhibits111: Pfizer Inc. - Key offerings
Exhibits112: Sanofi - Overview
Exhibits113: Sanofi - Business segments
Exhibits114: Sanofi - Key news
Exhibits115: Sanofi - Key offerings
Exhibits116: Sanofi - Segment focus
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Neurologic Disorders Therapeutics Market 2022-2026
Technavio has been monitoring the neurologic disorders therapeutics market and it is poised to grow by $ 33.46 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the neurologic disorders therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the approval of novel drugs, alliances, and collaborations, and changing lifestyles.
The neurologic disorders therapeutics market analysis includes application segment and geographic landscape.
Technavio's neurologic disorders therapeutics market is segmented as below:
By Application
• CNS
• PNS
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advent of regenerative medicines as one of the prime reasons driving the neurologic disorders therapeutics market growth during the next few years. Also, drug reformulations and advances in the diagnosis of neurodegenerative indications will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the neurologic disorders therapeutics market covers the following areas:
• Neurologic disorders therapeutics market sizing
• Neurologic disorders therapeutics market forecast
• Neurologic disorders therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurologic disorders therapeutics market vendors that include AbbVie Inc., Acadia Pharmaceuticals Inc., Acorda Therapeutics Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson, and Johnson, Merck KGaA, Mylan NV, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and USWM LLC. Also, the neurologic disorders therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/neurologic-disorders-therapeutics-market-industry-size-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 CNS - Market size and forecast 2021-2026
o Exhibit 28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on CNS - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
o 5.4 PNS - Market size and forecast 2021-2026
o Exhibit 32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on PNS - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 Biogen Inc.
o Exhibit 88: Biogen Inc. - Overview
o Exhibit 89: Biogen Inc. - Product / Service
o Exhibit 90: Biogen Inc. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 91: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 92: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 93: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 H Lundbeck AS
o Exhibit 96: H Lundbeck AS - Overview
o Exhibit 97: H Lundbeck AS - Product / Service
o Exhibit 98: H Lundbeck AS - Key offerings
o 10.7 Johnson and Johnson
o Exhibit 99: Johnson and Johnson - Overview
o Exhibit 100: Johnson and Johnson - Business segments
o Exhibit 101: Johnson and Johnson - Key news
o Exhibit 102: Johnson and Johnson - Key offerings
o Exhibit 103: Johnson and Johnson - Segment focus
o 10.8 Novartis AG
o Exhibit 104: Novartis AG - Overview
o Exhibit 105: Novartis AG - Business segments
o Exhibit 106: Novartis AG - Key offerings
o Exhibit 107: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 108: Pfizer Inc. - Overview
o Exhibit 109: Pfizer Inc. - Product / Service
o Exhibit 110: Pfizer Inc. - Key news
o Exhibit 111: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 112: Sanofi - Overview
o Exhibit 113: Sanofi - Business segments
o Exhibit 114: Sanofi - Key news
o Exhibit 115: Sanofi - Key offerings
o Exhibit 116: Sanofi - Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on CNS - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on PNS - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ billion)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ billion)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Biogen Inc. - Overview
Exhibits89: Biogen Inc. - Product / Service
Exhibits90: Biogen Inc. - Key offerings
Exhibits91: F. Hoffmann La Roche Ltd. - Overview
Exhibits92: F. Hoffmann La Roche Ltd. - Business segments
Exhibits93: F. Hoffmann La Roche Ltd. - Key news
Exhibits94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits96: H Lundbeck AS - Overview
Exhibits97: H Lundbeck AS - Product / Service
Exhibits98: H Lundbeck AS - Key offerings
Exhibits99: Johnson and Johnson - Overview
Exhibits100: Johnson and Johnson - Business segments
Exhibits101: Johnson and Johnson - Key news
Exhibits102: Johnson and Johnson - Key offerings
Exhibits103: Johnson and Johnson - Segment focus
Exhibits104: Novartis AG - Overview
Exhibits105: Novartis AG - Business segments
Exhibits106: Novartis AG - Key offerings
Exhibits107: Novartis AG - Segment focus
Exhibits108: Pfizer Inc. - Overview
Exhibits109: Pfizer Inc. - Product / Service
Exhibits110: Pfizer Inc. - Key news
Exhibits111: Pfizer Inc. - Key offerings
Exhibits112: Sanofi - Overview
Exhibits113: Sanofi - Business segments
Exhibits114: Sanofi - Key news
Exhibits115: Sanofi - Key offerings
Exhibits116: Sanofi - Segment focus
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/18 10:26

155.35 円

164.28 円

199.02 円

ページTOPに戻る